2Uslan DZ,Sohail MR, St Sauver JL,et al. Permanent pacemaker and implantable cardioverter-defibrillator infection: a population- basedstudy. Arch Intern Med, 2007,167:669-675.
3Greenspon AJ,Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter- defibrillators in the United States 1993 to 2008. J Am Coll Cardiol, 2011,58 : 1001-1006.
4BaddourLM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation, 2010,121:458-477.
5Vikatmaa P, Juutilainen V, Kuukasjarvi P, et al. Negative pressure wound therapy: a systematic review on effectiveness and safety. Eur J Vasc Endovasc Surg, 2008,36:438-448.
6Satsu T, Onoe M. Vacuum-assisted wound closure for pacemaker infection. Pacing Clin Electrophysiol, 2010,33:426-430.
7Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter- defibrillator infections. J Am Coil Cardiol, 2007,49:1851-1859.
8Sandoe JA, Barlow G, Chambers JB, ctal. Guidelines for the diagnosis, prevention and management of implantable cardiac eleclronic device infection. Reporl of a joint Working Party project on behalf of the British Sxciety for Antimicrobial Chcmolherapy ( BSAC, host organization ), British Hearl Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Sciety (BHVS) and Brhish Society for Echocardiography ( IK%E ) [ J ]. J Antimicrob Chemolher, 2015,70 (2), 325-359.
